FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2487119780> ?p ?o ?g. }

• W2487119780 abstract "Abediterol is a novel, once-daily long-acting β2-agonist in development for the treatment of chronic obstructive pulmonary disease (COPD) and asthma in combination with an anti-inflammatory agent. This Phase IIa, randomised, double-blind, crossover study investigated the bronchodilation, safety, tolerability and pharmacokinetics of abediterol in patients with moderate to severe COPD. Seventy patients (aged ≥40 years, Global initiative for chronic Obstructive Lung Disease Stage II/III) were randomised (1:1:1:1:1:1) to single doses of abediterol 0.625, 2.5, 5 or 10 μg, indacaterol 150 μg or placebo. Spirometry was performed up to 36 h post-dose. Pharmacokinetics were assessed in a subset of patients (N = 20). Safety and tolerability were evaluated throughout the study. Abediterol (all doses) significantly improved change from baseline in trough forced expiratory volume in 1 s (FEV1) compared with placebo (0.102, 0.203, 0.233 and 0.259 L for abediterol 0.625, 2.5, 5 and 10 μg, respectively; all p < 0.0001; primary endpoint). Abediterol 2.5, 5 and 10 μg significantly improved trough FEV1 compared with indacaterol 150 μg (0.092, 0.122 and 0.148 L, respectively; all p < 0.0001). Improvements in bronchodilation were maintained at all time points post-dose versus placebo (all abediterol doses) and from 15 or 30 min post-dose versus indacaterol 150 μg with abediterol 2.5, 5 and 10 μg (all p < 0.05). Abediterol had low systemic exposure; incidence of treatment-emergent adverse events was similar between treatment groups. All doses of abediterol (0.625–10 μg) provided clinically and statistically significant, dose-dependent improvements in bronchodilation versus placebo, and abediterol 2.5, 5 and 10 μg gave significant improvements versus indacaterol. All doses of abediterol were safe and well tolerated in patients with COPD. Clinicaltrials.gov NCT01425814 . Registered 29 August 2011." @default.
• W2487119780 created "2016-08-23" @default.
• W2487119780 creator A5009588067 @default.
• W2487119780 creator A5014141473 @default.
• W2487119780 creator A5014714297 @default.
• W2487119780 creator A5042080166 @default.
• W2487119780 creator A5048563320 @default.
• W2487119780 creator A5052391812 @default.
• W2487119780 creator A5063650460 @default.
• W2487119780 creator A5073147327 @default.
• W2487119780 date "2016-07-20" @default.
• W2487119780 modified "2023-10-18" @default.
• W2487119780 title "Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD" @default.
• W2487119780 cites W1993592748 @default.
• W2487119780 cites W1997210895 @default.
• W2487119780 cites W2003529117 @default.
• W2487119780 cites W2036139947 @default.
• W2487119780 cites W2061579085 @default.
• W2487119780 cites W2072228223 @default.
• W2487119780 cites W2102590607 @default.
• W2487119780 cites W2105402505 @default.
• W2487119780 cites W2127951128 @default.
• W2487119780 cites W2128740418 @default.
• W2487119780 cites W2149088199 @default.
• W2487119780 cites W2154497821 @default.
• W2487119780 cites W2273193217 @default.
• W2487119780 cites W4211263216 @default.
• W2487119780 doi "https://doi.org/10.1186/s12890-016-0266-5" @default.
• W2487119780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4955259" @default.
• W2487119780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27439370" @default.
• W2487119780 hasPublicationYear "2016" @default.
• W2487119780 type Work @default.
• W2487119780 sameAs 2487119780 @default.
• W2487119780 citedByCount "12" @default.
• W2487119780 countsByYear W24871197802017 @default.
• W2487119780 countsByYear W24871197802018 @default.
• W2487119780 countsByYear W24871197802020 @default.
• W2487119780 countsByYear W24871197802021 @default.
• W2487119780 countsByYear W24871197802022 @default.
• W2487119780 countsByYear W24871197802023 @default.
• W2487119780 crossrefType "journal-article" @default.
• W2487119780 hasAuthorship W2487119780A5009588067 @default.
• W2487119780 hasAuthorship W2487119780A5014141473 @default.
• W2487119780 hasAuthorship W2487119780A5014714297 @default.
• W2487119780 hasAuthorship W2487119780A5042080166 @default.
• W2487119780 hasAuthorship W2487119780A5048563320 @default.
• W2487119780 hasAuthorship W2487119780A5052391812 @default.
• W2487119780 hasAuthorship W2487119780A5063650460 @default.
• W2487119780 hasAuthorship W2487119780A5073147327 @default.
• W2487119780 hasBestOaLocation W24871197801 @default.
• W2487119780 hasConcept C112705442 @default.
• W2487119780 hasConcept C126322002 @default.
• W2487119780 hasConcept C142724271 @default.
• W2487119780 hasConcept C197934379 @default.
• W2487119780 hasConcept C203092338 @default.
• W2487119780 hasConcept C204787440 @default.
• W2487119780 hasConcept C22979827 @default.
• W2487119780 hasConcept C27081682 @default.
• W2487119780 hasConcept C2776042228 @default.
• W2487119780 hasConcept C2776136866 @default.
• W2487119780 hasConcept C2776312127 @default.
• W2487119780 hasConcept C2776780178 @default.
• W2487119780 hasConcept C2778375690 @default.
• W2487119780 hasConcept C2778884479 @default.
• W2487119780 hasConcept C2779871671 @default.
• W2487119780 hasConcept C2780333948 @default.
• W2487119780 hasConcept C2781018748 @default.
• W2487119780 hasConcept C2908646376 @default.
• W2487119780 hasConcept C2991744798 @default.
• W2487119780 hasConcept C42219234 @default.
• W2487119780 hasConcept C535046627 @default.
• W2487119780 hasConcept C71924100 @default.
• W2487119780 hasConcept C87813604 @default.
• W2487119780 hasConceptScore W2487119780C112705442 @default.
• W2487119780 hasConceptScore W2487119780C126322002 @default.
• W2487119780 hasConceptScore W2487119780C142724271 @default.
• W2487119780 hasConceptScore W2487119780C197934379 @default.
• W2487119780 hasConceptScore W2487119780C203092338 @default.
• W2487119780 hasConceptScore W2487119780C204787440 @default.
• W2487119780 hasConceptScore W2487119780C22979827 @default.
• W2487119780 hasConceptScore W2487119780C27081682 @default.
• W2487119780 hasConceptScore W2487119780C2776042228 @default.
• W2487119780 hasConceptScore W2487119780C2776136866 @default.
• W2487119780 hasConceptScore W2487119780C2776312127 @default.
• W2487119780 hasConceptScore W2487119780C2776780178 @default.
• W2487119780 hasConceptScore W2487119780C2778375690 @default.
• W2487119780 hasConceptScore W2487119780C2778884479 @default.
• W2487119780 hasConceptScore W2487119780C2779871671 @default.
• W2487119780 hasConceptScore W2487119780C2780333948 @default.
• W2487119780 hasConceptScore W2487119780C2781018748 @default.
• W2487119780 hasConceptScore W2487119780C2908646376 @default.
• W2487119780 hasConceptScore W2487119780C2991744798 @default.
• W2487119780 hasConceptScore W2487119780C42219234 @default.
• W2487119780 hasConceptScore W2487119780C535046627 @default.
• W2487119780 hasConceptScore W2487119780C71924100 @default.
• W2487119780 hasConceptScore W2487119780C87813604 @default.
• W2487119780 hasIssue "1" @default.
• W2487119780 hasLocation W24871197801 @default.
• W2487119780 hasLocation W24871197802 @default.
• W2487119780 hasLocation W24871197803 @default.

• next